The Molecular Sciences Software Institute (MolSSI), based in Virginia Tech’s Corporate Research Center, has launched an open-source website that will allow biomolecular scientists from around the world to share computer-aided drug-testing simulations targeting the protein at the center of COVID-19.
“The nature of this pandemic requires rapid and flexible response. This repository, and the data within, are designed to get the information out quickly. Researchers really wanted to get their data out in front of other scientists even though it had not necessarily been through the peer review process yet,” said T. Daniel Crawford, lead director of the institute and a University Distinguished Professor in the Department of Chemistry, part of the Virginia Tech College of Science.